TP53 and non-small cell lung carcinoma: The observation of higher SRA737-induced γH2AX-foci numbers following treatment of the TP53 MUT NSCLC and CRC cells was indicative of SRA737 having a potentially greater anti-proliferative effect in the MUT cells than in WT cells, via the formation of lethal DSB damage [39].